GLP-1 / glucagon dual agonist (investigational)
An investigational dual GLP-1/glucagon receptor agonist studied for weight management.
Early trial interest; long-term efficacy and safety data are still being gathered.
Unregulated outside trials; gastrointestinal effects are reported in studies.
Investigational — not approved or marketed as a medicine in Australia.
No lawful consumer supply. Access is only via an approved clinical trial.
This entry is general information about Mazdutide, not a recommendation to use it. We don’t provide dosing, protocols or sourcing. Speak to a registered practitioner.
This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.